Dr. Ben Boursi Reviews

A 28-year-old software developer from Tel Aviv presented with unexplained weight loss and night sweats. Dr. Boursi diagnosed stage II Hodgkin's lymphoma. The patient underwent ABVD chemotherapy with complete response after 4 cycles, returning to work within 6 months with no family support due to being an only child of deceased parents.

A 72-year-old Bedouin grandmother from the Negev desert arrived with advanced gastric cancer discovered during a rare hospital visit. Dr. Boursi coordinated palliative care respecting her cultural wishes for minimal hospital time, arranging home hospice with weekly telehealth check-ins through a community health worker.

A 45-year-old Ethiopian immigrant construction worker presented with persistent cough and was found to have metastatic lung cancer with EGFR mutation. Dr. Boursi initiated targeted therapy with osimertinib, achieving significant tumor reduction. The patient's entire extended family attended every appointment, requiring Hebrew-Amharic medical interpretation.

An 8-year-old girl from an ultra-orthodox family in Bnei Brak was diagnosed with acute lymphoblastic leukemia. Dr. Boursi worked closely with rabbinical authorities to coordinate chemotherapy around Sabbath observances, achieving remission after 2.5 years of treatment with minimal religious compromise.

A 33-year-old Palestinian woman from East Jerusalem presented with advanced breast cancer discovered during her first pregnancy. Dr. Boursi coordinated a multidisciplinary team to safely administer chemotherapy during second trimester, delivering a healthy baby at 36 weeks before completing cancer treatment.

A 60-year-old retired IDF general with melanoma metastasis to brain was treated with immunotherapy combination therapy. Dr. Boursi managed severe immune-related colitis requiring hospitalization, eventually achieving complete response with the patient returning to marathon running within 18 months.

A 19-year-old university student from a wealthy family presented with testicular cancer that had metastasized to lungs. Despite family demands for treatment abroad, Dr. Boursi successfully treated with BEP chemotherapy achieving complete remission in 3 cycles, with the patient now cancer-free for 3 years.

A 52-year-old homeless man with alcohol use disorder was found to have esophageal cancer during a shelter medical screening. Dr. Boursi secured social housing and addiction treatment before initiating chemoradiation, achieving local control with ongoing supportive housing arrangement.

A 67-year-old Holocaust survivor with PTSD developed colon cancer with liver metastases. Dr. Boursi adapted treatment protocols to minimize hospital triggers, using home nursing for chemotherapy administration. The patient achieved partial response and maintained psychological stability throughout treatment.

A 41-year-old Arab-Israeli school teacher with triple-negative breast cancer participated in Dr. Boursi's clinical trial combining chemotherapy with novel immunotherapy. She experienced complete pathological response after neoadjuvant treatment, becoming the first complete responder in the trial cohort.

A 29-year-old professional athlete from Russia was diagnosed with osteosarcoma during sports physical. Dr. Boursi performed limb-salvage surgery with customized prosthesis followed by adjuvant chemotherapy, enabling return to professional competition at 80% pre-diagnosis performance level.

An 81-year-old Armenian grandmother with limited Hebrew proficiency presented with advanced ovarian cancer. Dr. Boursi arranged family-centered decision making with grandchildren serving as interpreters, opting for palliative chemotherapy that extended quality life by 2 years.

A 38-year-old single mother of twins was diagnosed with aggressive glioblastoma. Dr. Boursi coordinated experimental treatment with tumor treating fields while arranging social services for childcare during therapy. The patient maintained functional independence for 18 months before hospice transition.